Company profile: NephroGenex
1.1 - Company Overview
Company description
- Provider of an online platform (Pharmacy Mall) for ordering medications and pharmacy products with home delivery and professional consultations, offering erectile dysfunction treatments (Viagra, Cialis, Levitra, Female Viagra) and Diamox. Also a drug-development company focused on kidney disease and progression of diabetic kidney disease.
Products and services
- Viagra: A blood-flow–enhancing medication that treats erectile dysfunction by increasing penile circulation, resulting in stable, natural erections
- Pharmacy Mall: An online platform for ordering a wide range of medications and pharmacy products, offering home delivery and professional consultation services
- Cialis: An extended-duration drug for erectile dysfunction, with long-lasting effects up to 36 hours and improvement of male reproductive system function
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NephroGenex
CreatiVasc
HQ: United States
Website
- Description: Provider of innovative, easy-to-use vascular technologies and medical devices for the treatment of end-stage renal disease, addressing universal problems of vascular access for dialysis patients to improve survivability and quality of life; founded in 2004.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CreatiVasc company profile →
Tricida
HQ: United States
Website
- Description: Provider of pharmaceutical offerings within the healthcare industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tricida company profile →
Quanta Dialysis Technologies
HQ: United Kingdom
Website
- Description: Provider of advanced haemodialysis systems for use in the home and clinic, focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based, high-performance, compact haemodialysis system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quanta Dialysis Technologies company profile →
Redsense
HQ: Sweden
Website
- Description: Provider of a hemodialysis blood leak monitoring system using patented fiber optic technology, including the Redsense Alarm System, a disposable sensor patch, and an extension fiber to detect blood contact and alert for needle dislodgement or leakage; offers an automatic off-switch feature for compliant dialysis machines and training and education services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Redsense company profile →
Gambro
HQ: Sweden
Website
- Description: Provider of medical technology developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gambro company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NephroGenex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NephroGenex
2.2 - Growth funds investing in similar companies to NephroGenex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NephroGenex
4.2 - Public trading comparable groups for NephroGenex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →